Baby formula supply - Encouraging jobs report - Russia strikes Kyiv

The plant shut down in February after FDA inspectors began investigating four bacterial infections in infants who had consumed formula from the plant. As baby formula supplies dried up nationwide and under pressure from the White House, Abbott entered a consent decree with the FDA that laid out the steps needed to resume production at the facility.
...
Abbott said it will start production of EleCare and other specialty and metabolic formulas and the initial product release to consumers is expected to begin on June 20. But the production of Similac and other formulas is still on pause, Abbott said.
...
But the reopening of the plant isn't an immediate fix to the shortage. Since the specialty and metabolic formulas are initially being prioritized, they will be distributed through health care providers — not stores. Almost 74% of store shelves are empty, and 10 states are 90% out of baby formula.